Health
Moderna Announces New Drug Application Submitted to Import and Distribute Moderna’s COVID-19 Vaccine Candidate in Japan – Odessa American
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Mar 5, 2021–
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Mar 5, 2021–
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Takeda Pharmaceutical Co., Ltd (NYSE: TAK) submitted a New Drug Application to the Government of Japans Ministry of Health, Labour and Welfare (MHLW) to import and distribute Modernas vaccine candidate against COVID-19 (mRNA-1273 or TAK-919) in Japan. TAK-919 is Takedas development code for Modernas COVID-19 vaccine…
-
General23 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
General21 hours agoIslam Makhachev claims UFC welterweight belt with dominant win over Jack Della Maddalena
-
General12 hours agoAmbulance response times sluggish despite Tasmanian ramping ‘ban’ promise
-
General21 hours agoIs the Coalition up for the Net Zero fight?